Igene Biotechnology, Inc. (IGNE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Accolade Statistics
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
IGNE has 1.56 billion shares outstanding.
Current Share Class | 1.56B |
Shares Outstanding | 1.56B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.33 |
PB Ratio | -0.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.15
Current Ratio | 1.15 |
Quick Ratio | 1.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.22 |
Interest Coverage | -9.24 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -8.21% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -46.51% |
Revenue Per Employee | 267 |
Profits Per Employee | -131,882 |
Employee Count | 18 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | -30.11 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 1.16 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IGNE had revenue of 4,804 and -2.37 million in losses. Loss per share was -0.00.
Revenue | 4,804 |
Gross Profit | 40,847 |
Operating Income | -596,768 |
Pretax Income | -2.37M |
Net Income | -2.37M |
EBITDA | -426,981 |
EBIT | -596,768 |
Loss Per Share | -0.00 |
Balance Sheet
The company has 269,290 in cash and 363,874 in debt, giving a net cash position of -94,584 or -0.00 per share.
Cash & Cash Equivalents | 269,290 |
Total Debt | 363,874 |
Net Cash | -94,584 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -4.44M |
Book Value Per Share | -0.00 |
Working Capital | 312,110 |
Cash Flow
In the last 12 months, operating cash flow was -1.68 million and capital expenditures 16,623, giving a free cash flow of -1.67 million.
Operating Cash Flow | -1.68M |
Capital Expenditures | 16,623 |
Free Cash Flow | -1.67M |
FCF Per Share | -0.00 |
Margins
Gross Margin | 850.27% |
Operating Margin | -12,422.31% |
Pretax Margin | -49,414.72% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IGNE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.87% |
Shareholder Yield | n/a |
Earnings Yield | -151,685.81% |
FCF Yield | -106,413.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IGNE has an Altman Z-Score of -21.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -21.9 |
Piotroski F-Score | 2 |